Back to journals
Academic Journal

Journal of Pain and Symptom Management

2 Papers Indexed in Blossom

Data updated

Research Footprint

Journal of Pain and Symptom Management has 2 tracked papers indexed in Blossom (2023–2026) from 22 authors, most often covering Ketamine and Psilocybin, across Depressive Disorders, Major Depressive Disorder (MDD) and Anxiety Disorders.

Published Papers

Paywallindividual

Intranasal Ketamine for Existential Distress in Advanced Cancer

This secondary analysis of the INKeD-PC trial (n=15) found that three doses of intranasal racemic ketamine in patients with advanced cancer receiving palliative care led to clinically meaningful improvements in existential distress, anxiety, symptom burden, and quality of life, with psychological symptoms improving more than physical ones.

Published
Journal
Journal of Pain and Symptom Management
Authors
Aguiar, S., Makarious, M., Lipsitz, O., deVries, F. E., Doyle, Z., McIntyre, R. S., Rodin, G., Zimmermann, C., Mak, E., Hannon, B., Schulz-Quach, C., Al Kindy, A., Patel, Z., Rosenblat, J. D., Li, M.
Open Accessindividual

HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients with Cancer

This open-label study (n=12) investigates the potential of psilocybin-assisted group therapy (PAT) in cancer patients suffering from depression. Participants underwent preparatory sessions, a high-dose (25mg) psilocybin group session, and integration sessions over three weeks, with clinical outcomes measured at baseline, two weeks, and 26 weeks post-intervention. Results show significant decreases in depression symptoms and no serious adverse events, suggesting safety, feasibility, and possible efficacy of the therapy.

Published
Journal
Journal of Pain and Symptom Management
Authors
Lewis, B. R., Garland, E. L., Byrne, K., Durns, T., Hendrick, J., Beck, A., Thielking, P.

Quick Facts

Papers Indexed
2
h-Index
171
Open Access
No
Publisher
Elsevier
Country
United States
Website
Visit